News

Cantargia Presents Promising Preclinical Results on Anti-IL1RAP Antibody-Drug Conjugate (ADC) at a Major Cancer Conference
Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical models Anti-IL1RAP ADC targets ...
Le Lézard2h
Radiant Biotherapeutics Announces Poster Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting
Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to deliver first-in-class transformative therapies for patients facing life-changing disease, today ...
Communications of the ACM3h
Reversing the Fossilization of Computer Science Conferences
Computer science research famously distinguishes itself from other fields by the prevalent role of conferences as a publication venue rather than just a meeting opportunity. For two decades, academics ...
TMCnet5h
Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders
All posters will be available on the ‘Posters and Publications’ page of Cogent’s website. New Leadership Appointments Cogent also announced today that Ray Frost has joined Cogent as Senior Vice ...
University of California18h
What makes a UC education stand apart? Opportunities for hands-on learning and undergraduate research
For these UC students, hands-on research has led to class credit, money for school and a path to their dream future.
Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May
Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to optimize ...